We are live on ! Find out more
EGRX

Eagle Pharmaceuticals, Inc.
EGRX

Delisted

EGRX was delisted on the 2nd of October, 2024.

Back to rankings

119 hedge funds and large institutions have $1.04B invested in Eagle Pharmaceuticals, Inc. in 2015 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 50 increasing their positions, 34 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 34

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

0% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 26

1% less funds holding

Funds holding: 120 → 119 (-1)

4% less capital invested

Capital invested by funds: $1.08B → $1.04B (-$39.8M)

31% less call options, than puts

Call options by funds: $7.06M | Put options by funds: $10.2M

Holders
119
Holders Change
-1
Holders Change %
-0.83%
% of All Funds
3.32%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.17%
New
26
Increased
50
Reduced
34
Closed
26
Calls
$7.06M
Puts
$10.2M
Net Calls
-$3.17M
Net Calls Change
+$964K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$21.5M
2
HCMT
Highland Capital Management (Texas)
Texas
+$19.9M
3
CCM
Consonance Capital Management
New York
+$14.2M
4
Invesco
Invesco
Georgia
+$10.5M
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$6.15M

Top Sellers

Rank Fund Capital Flow
1
BIM
Bogle Investment Management
Massachusetts
-$12.9M
2
PA
Perceptive Advisors
New York
-$9.15M
3
ARTA
A.R.T. Advisors
New York
-$3.85M
4
Marshall Wace
Marshall Wace
United Kingdom
-$3.84M
5
AL
AJO LP
Pennsylvania
-$3.83M
Name Holding Trade Value Shares
Change 		Change in
Stake
RSS
51
Rosenblum Silverman Sutton
California
$1.66M +$702K +8,435 +61%
TG
52
TCW Group
California
$1.65M +$1.86M +22,309 New
GC
53
Guggenheim Capital
Illinois
$1.62M +$1.82M +21,935 New
AI
54
Analytic Investors
California
$1.47M +$1.65M +19,850 New
California Public Employees Retirement System
55
California Public Employees Retirement System
California
$1.4M +$740K +8,900 +89%
Wells Fargo
56
Wells Fargo
California
$1.38M +$1.31M +15,794 +557%
CAM
57
ClariVest Asset Management
California
$1.22M -$341K -4,093 -20%
NFA
58
Nationwide Fund Advisors
Ohio
$1.21M +$18.5K +222 +1%
Morgan Stanley
59
Morgan Stanley
New York
$1.2M -$660K -7,928 -33%
AllianceBernstein
60
AllianceBernstein
Tennessee
$1.16M -$2.5K -30 -0.2%
California State Teachers Retirement System (CalSTRS)
61
California State Teachers Retirement System (CalSTRS)
California
$1.16M – – –
BCM
62
Bridgeway Capital Management
Texas
$1.12M -$1.41M -16,968 -53%
Fidelity Investments
63
Fidelity Investments
Massachusetts
$1.12M +$1.26M +15,150 New
TA
64
Teachers Advisors
New York
$948K +$24.5K +294 +2%
Fisher Asset Management
65
Fisher Asset Management
Washington
$922K +$1.04M +12,461 New
New York State Common Retirement Fund
66
New York State Common Retirement Fund
New York
$846K +$210K +2,530 +28%
DCM
67
Driehaus Capital Management
Illinois
$835K -$2.02M -24,311 -68%
Swiss National Bank
68
Swiss National Bank
Switzerland
$822K +$133K +1,600 +17%
GCP
69
GSA Capital Partners
United Kingdom
$751K +$844K +10,145 New
SO
70
STRS Ohio
Ohio
$725K – – –
PNC Financial Services Group
71
PNC Financial Services Group
Pennsylvania
$694K +$25.1K +302 +3%
CCM
72
Cadence Capital Management
Massachusetts
$629K +$706K +8,490 New
SAMC
73
Shinko Asset Management Company
Japan
$607K +$682K +8,201 New
Federated Hermes
74
Federated Hermes
Pennsylvania
$596K +$669K +8,042 +57,443%
RhumbLine Advisers
75
RhumbLine Advisers
Massachusetts
$587K +$30.6K +368 +5%
1 2
3
4 5

EGRX Hedge Fund Activity: Q3 2015 in Review

119 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Eagle Pharmaceuticals, Inc. (EGRX) for Q3 2015, worth a combined $1.04B — down 3.7% from $1.08B a quarter earlier.

Fund positioning in EGRX was balanced in Q3 2015: 26 funds opened new positions, 26 closed out, 50 added to existing stakes and 34 trimmed.

The largest buyer was Vanguard Group, adding an estimated $21.5M. The largest seller was Bogle Investment Management, exiting entirely with an estimated $12.9M sold.

  • 119 institutional investors held Eagle Pharmaceuticals, Inc. (EGRX) as of Q3 2015, down from 120 in Q2 2015.
  • Funds reported $1.04B of Eagle Pharmaceuticals, Inc. stock for Q3 2015, down 3.7% quarter-over-quarter.
  • 26 funds opened new Eagle Pharmaceuticals, Inc. positions in Q3 2015 and 26 closed out, a net change of 0 holders.
  • The largest Eagle Pharmaceuticals, Inc. buyer in Q3 2015 was Vanguard Group, an estimated $21.5M added.
  • The largest Eagle Pharmaceuticals, Inc. seller in Q3 2015 was Bogle Investment Management, an estimated $12.9M sold.

Based on aggregated 13F filings for Q3 2015.